Cart summary

You have no items in your shopping cart.

ACY-738

SKU: orb1304133

Description

ACY-738 is a potent and selective HDAC6 inhibitor with an IC50 of 1.7 nM, exhibiting approximately 100-fold selectivity over Class I HDACs. This small molecule is a valuable research tool for investigating HDAC6 biology in cellular and animal models of oncology, neurology, and immunology.

Research Area

Epigenetics & Chromatin, Molecular Biology

Images & Validation

Key Properties

CAS Number1375465-91-0
MW270.29
Purity99.89% (May vary between batches)
FormulaC14H14N4O2
SMILESN(C1(CC1)C2=CC=CC=C2)C=3N=CC(C(NO)=O)=CN3
TargetHDAC
SolubilityDMSO:50 mg/mL (184.99 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.4 mM)

Bioactivity

Target IC50
HDAC2:128 nM|HDAC1:94 nM|HDAC6:1.7 nM|HDAC3:218 nM
In Vivo
ACY-738 administered at a dosage of 5 mg/kg notably increases α-tubulin acetylation in whole-brain lysates, whereas a higher dosage (50 mg/kg) fails to enhance locomotor activity in wild-type (WT) mice within a home cage setting. At a dosage of 5 mg/kg by body weight (BW), ACY-738 influences B cell differentiation in bone marrow (BM) without significantly impacting immunoglobulin G (IgG) and complement component 3 (C3) deposition in NZB/W mice. This dosage also achieves a peak plasma concentration of 1310 ng/mL approximately 0.0830 hours post-treatment. When the dosage is increased to 20 mg/kg, ACY-738 markedly reduces the severity of proteinuria in NZB/W F1 mice and significantly lowers anti-double-stranded DNA (anti-dsDNA) production as well as glomerular interleukin-6 (IL-6) and interleukin-10 (IL-10) mRNA levels by more than 50% in NZB/W mice; the latter being reduced to non-detectable levels with the 20 mg/kg treatment. Additionally, both 5 and 20 mg/kg dosages of ACY-738 decrease serum interleukin-1 beta (IL-1β) production as the NZB/W mice age.
In Vitro
ACY-738 increases the acetylated (lysine 40) fraction of α-tubulin in RN46A-B14 cells at the concentration of 2.5 μM. The effect that ACY-738 (10 μM) induces cell death is similar to LBH589 and FK228.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ACY738, ACY-738, ACY 738, inhibit, HDAC6, HDAC, Inhibitor, Histone deacetylases

Similar Products

  • ACY-738 [orb1226416]

    >98% (HPLC)

    1375465-91-0

    270.2866

    C14H14N4O2

    10 mg, 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 1 g, 500 mg, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

ACY-738 (orb1304133)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 90.00
2 mg
$ 100.00
5 mg
$ 140.00
1 ml x 10 mM (in DMSO)
$ 150.00
10 mg
$ 220.00
25 mg
$ 340.00
50 mg
$ 530.00
100 mg
$ 690.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry